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Deldicque L, Cani PD, Philp A, Raymackers JM, Meakin PJ,
Ashford ML, Delzenne NM, Francaux M, Baar K. The unfolded
protein response is activated in skeletal muscle by high-fat feeding:
potential role in the downregulation of protein synthesis. Am J Physiol
Endocrinol Metab 299: E695–E705, 2010. First published May 25,
2010; doi:10.1152/ajpendo.00038.2010.—High-fat diets are known to
decrease muscle protein synthesis, the adaptation to overload, and
insulin sensitivity. Conditions that disrupt endoplasmic reticulum
(ER) homeostasis lead to the activation of the unfolded protein
response (UPR) that is associated with decreases in protein synthesis,
chronic inflammation, and insulin resistance. The purpose of the
present study was to establish whether ER stress is induced by a
high-fat diet in skeletal muscle and whether ER stress can decrease
mTORC1 activity and protein synthesis in muscle cells. Two inde-
pendent protocols of high-fat feeding activated the UPR in mice. In
the first study, mice consuming a high-fat diet containing 70% fat and
1% carbohydrates for 6 wk showed higher markers of the UPR (BiP,
IRE1, and MBTPS2) in the soleus and in the tibialis anterior muscles
and ATF4 in the tibialis anterior (P  0.05). In the second study, a
20-wk high-fat diet containing 46% fat and 36% carbohydrates also
increased BiP, IRE1, and phospho-PERK protein and the expression
of ATF4, CHOP, and both the spliced and unspliced forms of XBP1
in the plantar flexors (P  0.05). In C2C12 muscle cells, tunicamycin,
thapsigargin, and palmitic acid all increased UPR markers and de-
creased phosphorylation of S6K1 (P  0.05). Collectively, these data
show that a high-fat diet activates the UPR in mouse skeletal muscle
in vivo. In addition, in vitro studies indicate that palmitic acid, and
other well-known ER stress inducers, triggered the UPR in myogenic
cells and led to a decrease in protein synthesis and mTORC1 activity.
endoplasmic reticulum stress; binding protein; X box binding pro-
tein-1; ribosomal protein S6 kinase; protein synthesis
A HIGH-FAT DIET IS KNOWN to affect the physiology of skeletal
muscle: preventing skeletal muscle hypertrophy in response to
loading (39). It is possible that, over time, decreased load-
induced muscle protein synthesis would result in a decrease in
lean body mass and, as a result, a decrease in the capacity to
take up and oxidize glucose, contributing to insulin resistance
and the metabolic syndrome. Even though some hypotheses
have been formulated to explain how a high-fat diet could
affect muscle protein synthesis, no definitive mechanism has
been presented. What is clear is that following a high-fat diet
there is a decrease in ribosomal biogenesis and in the activation
of mammalian target of rapamycin complex 1 (mTORC1) in
response to overload (39).
The endoplasmic reticulum (ER) is where folding and post-
translational modifications of proteins occur. Certain condi-
tions, such as high lipids, glucose deprivation, or increased
synthesis of secretory proteins disrupt ER homeostasis and lead
to the accumulation of unfolded or misfolded proteins within
the ER lumen (54). To cope with this, cells activate the
unfolded protein response (UPR), a series of events that serve
to restore ER function (21, 23, 35, 48). The UPR has three
main effectors: ATF6 (activating transcription factor 6), IRE1
(inositol-requiring enzyme 1), and PERK (protein kinase
R-like ER protein kinase). In the basal (inactive) state, each of
these factors associates with the protein chaperone BiP/GRP78
(binding protein/glucose-regulated protein-78), a member of
the Hsp70 (heat shock protein-70) family. Upon accumulation
of unfolded/misfolded proteins, ATF6, IRE1, and PERK are
released from BiP/GRP78 and become activated. The down-
stream effect of ATF6, IRE1, and PERK release is the
induction of genes, such as XBP1 (X box binding protein-1),
CHOP [CCAAT/enhancer binding protein (C/EBP) homolo-
gous protein], and ATF4 (activating transcription factor 4),
which lead to a decrease in protein synthesis and increase in
protein folding capacity. When the unfolded protein response
fails, the result is cell death, mostly in the form of apoptosis
(19). Activation of the PERK-eIF2-ATF4, the IRE1-XBP1,
and the ATF6 pathways upregulates the transcription factor
CHOP, which in turn downregulates Bcl-2 (B-cell leukemia/
lymphoma 2) expression, resulting in mitochondrial cyto-
chrome c release (19). In addition, IRE1-ASK1(apoptosis
signal-regulating kinase-1)-JNK signaling activates the pro-
apoptotic Bcl-2 family member BIM while inhibiting the
antiapoptotic protein Bcl-2 (49). IRE1 activation also triggers
the recruitment of caspase-12, a protein with homology to the
caspase family of cysteine proteases involved in apoptosis and
inflammatory cytokine processing (50).
Whereas ER stress has been widely studied in pancreatic
islets, liver, and adipose tissue, where it has been proposed to
be involved in the pathogenesis of diabetes (7, 10, 15, 37, 41),
much less information exists about ER stress in skeletal mus-
cle. In muscle, ER stress has been observed in myopathies such
as myotonic dystrophy type 1 (13) and sporadic inclusion body
myositis (26, 47). In addition, ER stress can be triggered by
proinflammatory cytokines and lipids (33, 53). Since both of
these factors are increased in obesity and diabetes, it is possible
that ER stress may be activated in pathological metabolic
conditions, leading to muscle wasting and further dysfunction
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(32). In fact, a recent study in diabetic patients indicated that
markers of the UPR were increased in cells isolated from
muscle biopsies and cultured in the presence of palmitate (34),
suggesting that ER stress is present in muscle in vivo, although
this has yet to be shown. Even though there are suggestions
that ER stress is induced in vivo, at least one study reported
that ER stress markers were not altered in skeletal muscle of
obese and high-fat-fed animals compared with controls (29).
Due to the important role of skeletal muscle in whole body
metabolic regulation and the possibility that ER stress can
regulate protein synthesis, muscle size, and insulin resistance,
we sought to establish whether ER stress was induced by a
high-fat diet and whether ER stress would decrease protein
synthesis and mTORC1 activity. Therefore, we first tested
whether the unfolded protein response was increased in mouse
skeletal muscle after two different high-fat diet protocols.
Second, we determined the effect of agents known to induce
ER stress (9, 29, 36, 40, 46), such as tunicamycin, thapsigargin
and palmitic acid on mTORC1 activity and protein synthesis in
C2C12 muscle cells.
MATERIALS AND METHODS
Protocols
Cell cultures. C2C12 murine skeletal muscle myoblasts (ATCC)
were seeded in 150-mm-diameter culture dishes and grown in Dul-
beccos’s modified Eagle medium (DMEM, Life Technologies) sup-
plemented with 10% fetal bovine serum and 1% penicillin-streptomy-
cin (5,000 U/5,000 g/ml). Cells were then plated in six-well plates
until reaching 90% confluence. At that time, the proliferation medium
was replaced with a differentiation medium containing 2% horse
serum and 1% penicillin-streptomycin (5,000 U/5,000 g/ml). After
96 h of differentiation, tunicamycin (TN, 1 g/ml), thapsigargin (TG,
200 nM), or palmitic acid (PA, 1 mM) plus 2% BSA was added for 17
h. TN and TG are well-documented chemical inducers of ER stress by
blocking N-glycosylation and calcium entry into the ER, respectively,
and were used as positive controls. At the end of the incubation
period, cells were harvested, and cell lysates were immediately frozen
at 80°C for subsequent analyses. All experiments were performed
three times in triplicates except the dose-response curves to PA.
Animal Studies. STUDY 1. Eight-week-old female C57BL/6J mice
(Laboratory of Experimental Surgery, UCLouvain, Belgium) were
housed in groups of seven per cage at 22°C on a 12:12-h light-dark
cycle and were given free access to diet and water. After 1 wk of
acclimation, mice were randomly assigned to either a control group
(Ctrl-1, n  7) or a high-fat diet group (HFD-1, n  7). The control
group ate standard chow, whereas the other group received a diet
containing 49.5 g fat (corn oil and lard)/100 g, 37 g protein (cow milk
casein)/100 g, and 1 g carbohydrate/100 g. This represents in
percent total energy: 72% fat, 28% protein, and 1% carbohydrate
(UAR). This diet is known to induce a marked diabetic and metabolic
stress state (3, 4). At the end of the 6 wk, 6-h-fasted mice were
terminally anesthetized by intraperitoneal injection of pentobarbital
sodium solution (using 60 mg/kg body wt, Nembutal, Sanofi). Tibialis
anterior and soleus muscles were removed as fast as possible and
immediately frozen in liquid nitrogen. All mouse experiments were
approved by the local ethics committee, and the housing conditions
were as specified by the Belgian Law of November 14, 1993, on the
protection of laboratory animals (Agreement no. LA 1220548).
STUDY 2. Eighteen- to twenty-wk-old C57BL/6J mice (Charles
River, UK) were housed at 22°C on a 12:12-h light-dark cycle and
were given free access to diet and water. Mice were randomly
assigned to either a control group (Ctrl-2, n  12) or a HFD group
(HFD-2, n 19). The control group ate standard chow (RM1, Special
Diets Services), whereas the other group received a diet containing
23.6 g fat (lard and soybean oil)/100 g, 21.3 g protein (casein)/100 g,
and 41.2 g carbohydrate/100 g (58V8, Test Diet). This represents in
percent total energy: 46% fat, 18% protein, and 36% carbohydrate. At
the end of the 20 wk, the mice were starved overnight prior to being
culled with an overdose of Euthatal (Merial Animal Health). Plantar
flexor muscles were removed as fast as possible and immediately
frozen in liquid nitrogen. All procedures conformed to the UK
Animals (Scientific Procedures) Act 1986 and were approved by the
ethical review committee of the University of Dundee (UK).
Protein extraction, SDS/PAGE, and immunoblotting. Cells were
rinsed once with PBS and harvested in a lysis buffer containing 20
mM Tris, pH 7.0, 270 mM sucrose, 5 mM EGTA, 1 mM EDTA, 1%
Triton X-100, 1 mM sodium orthovanadate, 50 mM sodium -glyc-
erophosphate, 5 mM sodium pyrophosphate, 50 mM sodium fluoride,
1 mM DTT, and a protease inhibitor cocktail containing 1 mM
EDTA (Roche Applied Science). Frozen muscles were ground in a
mortar and homogenized as previously described (5a). The homog-
enates were then centrifuged for 10 min at 10,000 g, and the
supernatants were immediately stored at 80°C. Protein concen-
tration was determined using the DC protein assay kit (Bio-Rad
Laboratories).
Cell lysates (15 g for cell culture proteins and 60 g for skeletal
muscle proteins) were combined with Laemmli sample buffer and
separated by SDS-PAGE. After electrophoretic separation at 40 mA
for 1 h, the proteins were transferred to a PVDF membrane at 80 V for
2 h for Western blot analysis. Membranes were then incubated in a 5%
Blotto solution. Subsequently, membranes were incubated with the
following antibodies overnight at 4°C: eEF2 (eukaryotic elongation
factor 2), S6K1 (70-kDa ribosomal protein S6 kinase), phospho-S6K1
Thr389, phospho-S6K1 Thr421/Ser424, BiP, PDI (protein disulfide
isomerase), MBTPS2 (membrane-bound transcription factor protease
site 2), IRE1, phospho-PERK Thr980, caspase-12, caspase-3, PARP
(poly ADP-ribose polymerase), ATF6, and GAPDH (glyceraldehyde-
3-phosphate dehydrogenase). All antibodies were from Cell Signal-
ing, except the GAPDH was from Abcam, the ATF6 was from
Imgenex, and the phospho-S6K1 Thr389, phospho-S6K1 Thr421/
Ser424, and S6K1 were from Santa Cruz Biotechnology.
Membranes were washed in TBS-T and incubated for 1 h at room
temperature in a secondary antibody conjugated to horseradish per-
oxidase. After an additional three washes, chemiluminescence detec-
tion was carried out using an enhanced chemiluminescent Western
blotting kit (ECL Plus, Amersham Biosciences). The films were then
scanned on an ImageScanner using the Labscan software and quan-
tified with the Image Master 1D Image Analysis software (Amersham
Biosciences). Results are reported relative to eEF2 total for in vitro
experiments and to GAPDH for in vivo experiments. Preliminary
experiments show that eEF2 and GAPDH expressions did not change
after the treatments. A value of 1 was arbitrarily assigned to the
control conditions, which were used as a reference for the other
conditions.
RNA extraction and quantitative real-time PCR. Total RNA from
the cells of one 35-mm well (6-well plates) or from 20 mg of frozen
tissue samples was extracted with 1 ml of TriPure reagent (Roche)
according to the instructions provided by the manufacturer (Roche
Diagnostics). RNA was quantified by spectrophotometry (260 nm)
and its concentration adjusted to 1 g/l by using RNase-free water.
Since soleus muscles have low protein yields (5–6 mg), the RNA
concentrations obtained after extraction were too low to perform the
reverse transcription reaction. For tibialis anterior and C2C12 cells,
cDNA was prepared by reverse transcription of 1 g of total RNA
using the reverse transcription system (Promega). SYBR Green was
used for real-time PCR detection. Real-time PCR primers were
designed (Table 1) for mouse CHOP, ATF4, spliced (s) XBP1,
unspliced (u) XBP1, GAPDH, and RPL19 (ribosomal protein L19).
Specific primers were designed to recognize the spliced, or active,
form of XBP1 (XBP1s) vs. the unspliced form (XBP1u). GAPDH was
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used as the reference gene for in vitro experiments and RPL19 for in
vivo experiments. All samples were run at least in duplicate in a single
96-well reaction plate, and the data were analyzed according to the
2CT method. The identity and purity of the amplified product were
checked through analysis of the melting curve carried out at the end
of amplification. A value of 1 was arbitrarily assigned to the control
condition to which the other conditions were reported.
Incorporation of [35S]methionine/cysteine. Cells were maintained
in serum-free DMEM while ER stress inducers were added for 17 h.
ER stress inducers were maintained in culture medium during the
whole experiment. Preliminary experiments confirm that the absence
of serum did not modify the UPR induced by TN, TG, or PA. One
hour before cell labeling, full DMEM was replaced with DMEM
lacking methionine and cysteine. After that preincubation period, 3.66
Ci of a [35S]methionine-cysteine mixture (EasyTag Express Protein
Labeling Mix, NEN Life Science Products) was added to each well,
and the cells were returned to the incubator for 2 h. Cells were then
rinsed twice with PBS and lysed in a buffer containing 20 mM Tris pH
7.4, 150 mM NaCl, 1 mM Igepal C630 (NP-40), 10% glycerol, 50
mM -glycerophosphate, 50 mM NaF, and a protease inhibitor
cocktail. Cell lysates were centrifuged for 2 min at 10,000 g, and 15
l of the supernatant was spotted on a Whatman paper in duplicate,
whereas a 20-l aliquot was saved to measure protein content in each
sample. Whatman papers were washed three times in 5% trichloro-
acetic acid containing cold methionine and cysteine, rinsed once in
ethanol, and dried at 37°C. Scintillating liquid (4 ml of Ultimagold,
PerkinElmer) was then added to the papers, and 35S incorporation was
counted in a scintillation counter (Beckman) for 2 min. Protein
content was measured with the DC protein assay (Bio-Rad) with BSA
as standard. Results were reported in femtomoles per minute per
milligram of protein. It should be specified that due to technical
difficulties the actual specific activity of the precursor pool was not
measured. It is possible that the uptake of 35S was different between
the treatment groups and that this contributed to the difference in
protein synthesis.
Glucose tolerance test. STUDY 1. An oral glucose tolerance test
(OGTT) (gavage with 1 mg glucose/g body wt; 20% glucose solution)
was performed on 6-h-fasted mice at the end of the 6-wk treatment.
Blood glucose was determined with a glucose meter (Roche Diagnos-
tics) on 3.5 l of blood collected from the tip of the tail vein 30 min
before and 0, 15, 30, 60, 90, and 120 min following glucose injection.
STUDY 2. An intraperitoneal glucose tolerance test (IPGTT; injected
with 2 mg glucose/g body wt; 25% glucose solution) was performed
on 16-h-fasted mice at the end of the 20-wk treatment. Blood glucose
was determined with a glucose meter (Bayer) on 1 l of blood
collected from the tip of the tail vein at 0, 15, 30, 45, 60, and 120 min
following glucose injection.
Cytokine quantification. Cytokine levels were determined in 12 l
of plasma using a kit (Bio-Plex Multiplex, Bio-Rad) and measured
using Luminex technology (Bio-Plex).
Statistical Analysis
The effect of the different treatments was tested by unpaired
Student’s t-test except the effect of HFD on mass gain and glucose
tolerance test. For these data, diet 	 time interactions were evaluated
using a two-way analysis of variance for repeated measured (RM
ANOVA). When appropriate, Student-Newman-Keuls post hoc tests
were applied. The significance threshold was set to P  0.05. Results
are presented as means 
 SE.
RESULTS
HFD-1 Increases Body Mass, Decreases Glucose Tolerance,
and Induces Inflammation
During HFD-1, mice fed with a normal diet increased body
mass by 20% (Fig. 1A). At the end of the 6 wk, HFD-1 mice
weighed 10% more than control mice (Fig. 1A, P  0.001).
HFD-1 increased visceral fat content by 50% (Fig. 1B, P 
0.05) compared with control mice. Mice fed HFD-1 were
glucose intolerant as indicated by the OGTT performed at the
end of the 6 wk (Fig. 1C). For the same amount of glucose
given orally, plasma glucose concentrations remained elevated
Table 1. Sequences of primers used for mRNA quantification by real-time RT-PCR
Forward Reverse
CHOP CCT AGC TTG GCT GAC AGA GG CTG CTC CTT CTC CTT CAT GC
ATF4 GAG CTT CCT GAA CAG CGA AGT G TGG CCA CCT CCA GAT AGT CAT C
XBP1s GAG TCC GCA GCA GGT G GTG TCA GAG TCC ATG GGA
XBP1u AAG AAC ACG CTT GGG AAT GG ACT CCC CTT GGC CTC CAC
GAPDH TGG AAA GCT GTG GCG TGA T TGC TTC ACC ACC TTC TTG AT
RPL19 GAA GGT CAA AGG GAA TGT GTT CA CCT TGT CTG CCT TCA GCT TGT
CHOP, CCAAT/enhancer binding protein homologous protein; ATF4, activating transcription factor 4; XBP1s and XBP1u, X box-binding protein-1, spliced
and unspiced; RPL19, ribosomal protein L19.
Fig. 1. Body mass, fat content, and oral glucose tolerance test (OGTT). A: mice
were weighed weekly and their body mass was reported relative to basal value.
B: at the end of the 6 wk, visceral fat content was precisely dissected and
weighed and reported to body mass. C and D: OGTT was performed on
6-h-fasted mice at the end of the 6-wk treatment. C: plasma glucose concen-
trations 30 min before and 0, 15, 30, 60, 90, and 120 min after oral glucose
load. D: area under curve (AUC) of glucose excursion after oral glucose load.
Results are means 
 SE. Ctrl-1, control 1; HFD-1, high-fat diet 1. *P  0.05,
**P  0.01, ***P  0.001 vs. Ctrl-1.
E697ER STRESS AND SKELETAL MUSCLE
AJP-Endocrinol Metab • VOL 299 • NOVEMBER 2010 • www.ajpendo.org
 o
n
 O
ctober 28, 2010 
ajpendo.physiology.org
D
ow
nloaded from
 
up to 90 min after gavage (Fig. 1C, P  0.05), whereas plasma
insulin concentrations were not different between groups (data
not shown). The area under the curve was increased 1.8-fold by
the HFD-1 (Fig. 1D, P  0.05). Inflammation was assessed by
measuring plasma levels of several pro- and anti-inflammatory
cytokines (Table 2). HFD-1 increased IL-6 and IL-10 concen-
trations by 250% (P  0.05). To confirm the inflammatory
state at the tissue level, the phosphorylation state of JNK (c-Jun
NH2-terminal kinase) and IKK (I-B kinase) were measured as
well as the mRNA expression of IL-1 and IL-6 in muscles and
liver. JNK and IKK/NF-B (nuclear factor -light-chain en-
hancer of activated B-cells) have been implicated in insulin
resistance and inflammation induced by ER stress through the
IRE1 pathway (11, 15). Phospho-JNK and phospho-IKK
were increased by HFD-1 in the soleus, and phospho-JNK was
increased in the liver. IL-1 mRNA level was increased and
IL-6 decreased by HFD-1 in the tibialis anterior [P  0.05;
Supplemental Fig. 1 (Supplemental materials are found in the
online version of this paper at the Journal website)].
HFD-1 Increases the Expression of Proteins Involved in
UPR
The UPR was measured in liver to ensure that ER stress was
induced by high-fat feeding, as already described in the liter-
ature (28, 52). In the liver, the protein expression of PDI,
IRE1, MBTPS2, and the phosphorylation of PERK, as well as
the mRNA expression of XBP1u, were more than doubled
(P  0.05; data not shown). Having shown that the UPR was
induced by high-fat feeding in a tissue known to be responsive
to ER stress, we determined whether the same response could
be observed in skeletal muscle.
Several UPR markers were higher in skeletal muscles of
HFD-1 than in control mice (Fig. 2). The changes were more
pronounced in slow-type soleus muscle (Fig. 2A) than in
fast-type tibialis anterior muscle (Fig. 2C). In the soleus (Fig.
2A), HFD increased the protein expression of BiP (P  0.05)
and MBTPS2 (P  0.001), the enzyme that cleaves ATF6 into
a functional transcription factor, eightfold and IRE1 (P 
0.05) fivefold. HFD also increased caspase-12 expression and
the absolute amount of cleaved, and thus potentially active,
caspase-12 (Fig. 2B, P 0.05). However, the ratio between the
cleaved and the total forms of caspase-12 after HFD was not
different from control conditions in soleus.
In the tibialis anterior muscle (Fig. 2C), HFD-1 doubled BiP
(P  0.05) and IRE1 (P  0.05) protein levels and tripled
MBTPS2 (P  0.05). At the transcriptional level, only ATF4
mRNA was increased (35%, P  0.05; Fig. 2E). HFD had no
effect on caspase-12 total expression but increased the absolute
amount of cleaved caspase-12, making the ratio of cleaved to
total caspase-12 significantly higher than in control conditions
in tibialis anterior (Fig. 2D, P  0.05). It is of note that,
contrary to soleus muscle, cleaved caspase-12 was not detect-
able in control conditions in tibialis anterior (Fig. 2D), whereas
total caspase-12 was observed.
HFD-2 Increases Body Mass And Decreases Glucose
Tolerance
To determine whether the effects of a HFD on ER stress
were specific to the 70% fat diet, we studied muscle from a
second HFD experiment (HFD-2) using a lower percentage of
fat (45%) for a longer period (20 wk). This diet was chosen as
it is more representative of the diet in the developed world.
Throughout the 20 wk of experiment, mice fed a normal diet
increased body mass by 30% (Fig. 3A). At the end of the 20
wk, HFD-2 mice weighed 20% more than control mice (Fig.
3A, P  0.001). HFD-2 almost doubled the percentage fat
mass (Fig. 3B, P  0.001) compared with control mice. Mice
fed HFD-2 were glucose intolerant as indicated by the IPGTT
performed at the end of the 20 wk (Fig. 3C, P  0.05). The
area under the curve was increased by 33% by the HFD-2 (Fig.
3D, P  0.05).
45% HFD-2 Increases Expression of Proteins and mRNAs
Involved in UPR
As observed after 70% HFD-1 for 6 wk, 45% HFD-2 for 20
wk increased several UPR markers in plantar flexor muscles
(Fig. 4). HFD-2 increased the protein expression of BiP by
30% (P  0.05), IRE1 by 200% (P  0.001), and the
phosphorylation of PERK by 50% (P 0.05). Cleaved-to-total
caspase-12 ratio tended to decrease in HFD-2 conditions with-
out reaching the statistical threshold (Fig. 4B). HFD-2 had a
more pronounced effect on the transcriptional regulation in-
duced by the UPR (Fig. 4C). HFD-2 almost doubled ATF4
(P  0.001) and CHOP mRNA (P  0.01) and tripled both
XBP1s and XBP1u forms (P  0.001).
UPR Is Induced by TN, TG, and PA In C2C12 Myogenic
Cells
Since both HFDs induced markers of ER stress, we next
sought to determine the effect of ER stress on muscle cell
function. The UPR was strongly activated by TN, TG, and PA
in C2C12 cells (Fig. 5). After a 17-h incubation with these
agents, BiP was increased more than 100-fold by TN and TG
and more than 30-fold by PA (Fig. 5A, P  0.001). IRE1
expression, which reflects the activation of the IRE1 pathway
(44), doubled in TN and PA conditions and increased fivefold
with TG (Fig. 5A, P  0.05). Phosphorylation of PERK was
increased 10-fold by TN and PA and 30-fold by TG (Fig. 5A,
P  0.05). ATF6 was reduced following PA incubation (Fig.
5A, P  0.01).
ER stress inducers decreased caspase-12 total expression but
increased the amount of cleaved caspase-12 except for PA,
which only decreased caspase-12 total expression, making the
ratio of cleaved to total caspase-12 significantly higher than in
control conditions (Fig. 5B, P  0.05).
Table 2. Plasma cytokine concentrations
Ctrl-1 HFD-1
IL-1 34 
 11.3 20 
 3.5
IL-1 26 
 6.2 18 
 2.5
IL-6 22 
 3.3 56 
 11.3*
IL-10 43 
 14.0 112 
 24.3*
IL-15 306 
 27.2 257 
 17.8
IL-18 440 
 107.7 593 
 189.8
MCP-1 107 
 13.1 120 
 12.4
MIP-1 139 
 10.6 178 
 18.7
TNF- 26 
 6.4 14 
 1.2
Values are means 
 SE. Ctrl-1, control 1; HFD-1, 6-wk high-fat diet;
MCP-1, monocyte chemoattractant protein-1; MIP-1, macrophage inflamma-
tory protein-1. *P  0.05 vs. Ctrl-1.
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Since ER stress induces responses at both the translational
and the transcriptional levels, we also analyzed the mRNA
levels of some well-documented transcriptional ER stress
markers: CHOP, ATF4, and XBP1 (Fig. 5C) (10, 18). ATF4
mRNA was doubled by TN, TG, and PA (P  0.001), and
CHOP mRNA was increased 10-fold in response to PA and
30-fold with TN and TG (P  0.001). XBP1s mRNA was
15-fold more abundant in TN and PA and 25-fold in TG than
in control conditions (Fig. 5C, P  0.001). The large increase
in the mRNA of the active form of XBP1 contrasted with the
more modest increase in the unspliced form induced by TN and
TG and even the decrease observed in PA conditions (Fig. 5C,
Fig. 2. 70% HFD-induced unfolded protein response (UPR) in mouse skeletal muscle. A–D: protein expression of BiP, IRE1, MBTPS2, PDI, and
phosphorylation of PERK (A and C) and caspase-12 expression and cleavage (B and D) in soleus and tibialis anterior muscles after 6-wk HFD-1. E: mRNA level
of ATF4, CHOP, XBP1s, and XBP1u in tibialis anterior after 6-wk HFD-1. Results are means 
 SE. A value of 1 was arbitrarily assigned to control conditions
to which HFD-1 were reported and expressed as fold basal. BiP, binding protein; IRE1, inositol-requiring enzyme 1; MBTPS2, membrane-bound transcription
factor protease site 2, PDI, protein disulfide isomerase; pPERK, phosphorylated protein kinase R-like endoplasmic reticulum (ER) protein kinase; GAPDH,
glyceraldehyde-3-phosphate dehydrogenase; ATF4, activating transcription factor 4; CHOP, C/EBP (CCAAT/enhancer binding protein) homologous protein;
XBP1s, spliced X box-binding protein-1; XBP1u, unspliced XBP1. *P  0.05, ***P  0.001 vs. Ctrl-1.
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P  0.001). The latter result may be related to the decrease in
ATF6 by PA, since the ATF6 pathway has been proposed as
the regulator of the transcription of the unspliced form of
XBP1, and IRE1 would make it active by enhancement of its
splicing (51).
The percentages of cleaved caspase-3 and cleaved PARP
were used as markers of apoptosis (Fig. 5D). No cleaved
caspase-3 was detectable in Ctrl and PA conditions, whereas
1.0% in TN and 0.7% in TG of total caspase-3 were in the
cleaved form (P  0.05). In the same way, no cleaved PARP
was detectable in Ctrl and PA conditions, whereas 3% and 8%
of total PARP were in the cleaved form following TN and TG
treatment, respectively (P  0.001).
The effect of PA on the UPR is dose dependent, as at lower
doses (250–500 M) the UPR was not affected or even
repressed, whereas at larger doses (750–1,000 M) BiP,
IRE1, and phospho-PERK were increased (Fig. 5E).
PA Decreases Protein Synthesis in C2C12 Myogenic Cells
PA did not affect the ability of insulin to increase 2-deoxy-
glucose (2-DG) uptake (data not shown) but decreased the rate
of 35S incorporation into proteins by 20% (Fig. 6A, P 0.001).
The decrease in protein synthesis suggested that mTORC1
activity might be altered by PA. As a marker of mTORC1
activity, we measured the phosphorylation of the mTORC1 site
on S6K1. Treatment for 17 h with PA resulted in a 50%
decrease in S6K1 phosphorylation at Thr389 (Fig. 6B, P 
0.01), indicating that mTORC1 activity was decreased by ER
stress. To determine whether the effect of PA on mTORC1
could have been mediated by ER stress, the effect of both TN
and TG on S6K1 phosphorylation was determined. As with
PA, treatment with TN or TG decreased S6K1 phosphoryla-
tion, indicating that the effects of PA on mTORC1 activity
could be mediated by the ER stress response. In high-fat-fed
mice, S6K1 phosphorylation tended to increase (Fig. 6C).
However, since the mice were in the fasted state, the mTORC1
site (Thr389) was barely detectable, and the changes in S6K
phosphorylation may be secondary to the altered hormonal
milieu.
To determine the dynamics of the relationship between ER
stress and mTORC1/S6K1, C2C12 myogenic cells were incu-
bated for 6 or 24-h with TN alone, insulin alone, or both TN
and insulin (Fig. 6D). After 6 h, the phosphorylation of PERK
and the expression of BiP were marginally increased by TN,
whereas phospho-S6K1 (Thr389) was increased by insulin even
in the presence of TN. After 24 h, BiP was still increased,
whereas PERK phosphorylation was not affected by TN. Phos-
phorylation of S6K1 by insulin at 24 h was repressed by TN.
These data indicate that activation of the mTORC/S6K1 path-
way by insulin does not induce ER stress in C2C12 myogenic
cells, whereas activation of the UPR represses the basal phos-
phorylation state of the mTORC/S6K1 pathway as well as its
activation by insulin.
DISCUSSION
The main findings of the present study are 1) that the UPR
is activated in mouse skeletal muscle by an HFD and in C2C12
cells by PA, and 2) that ER stress can decrease protein
synthesis and mTORC1 activity in muscle cells. This extends
previous work in the pancreas and liver (6, 28, 52), suggesting
that HFD results in ER stress in the primary metabolic organs.
The primary shortcoming of the paper is that the two HFDs
were not controlled for caloric intake, carbohydrate content,
sex of the mice, or the age of the mice at the onset of the diet.
This is simply because, after discovering that HFD-1 induced
the UPR, we wanted to confirm that this was not simply due to
the extremely high fat content or the extremely low carbohy-
drate content. In fact, glucose deprivation has previously been
shown to induce ER stress (12). It is thus possible that glucose
deprivation, together with high levels of lipids, would have
triggered the UPR. To eliminate this possibility, we wanted to
test a more physiological diet and turned to our collaborators
who had recently finished the study using HFD-2 looking at
insulin resistance. Using the muscles, we confirmed that the
UPR was activated in a lower-fat, higher-carbohydrate, “West-
ern” diet. It was never our intention to compare the diets, only
to confirm the presence of the UPR.
Recently, ER stress and UPR have gained major interest, as
they have been proposed to be involved in the pathogenesis of
diabetes (7), Parkinson’s, Alzheimer’s, and Huntington’s dis-
ease (8, 14, 20) as well as hypoxia/ischemia-induced heart and
brain damage (5). In diabetes, ER stress might contribute to
pancreatic -cell dysfunction and death as well as insulin
resistance in the liver and adipose tissue (41). Despite its
potential role in metabolic disease, there are a paucity of
studies on ER stress in skeletal muscle.
In the first study, mice were placed on a diet containing 70%
fat for a period of 6 wk. In this study, the effect of high-fat
Fig. 3. Body mass, percent fat mass, and ip glucose tolerance test (IPGTT).
A: mice were weighed weekly and their body mass was reported relative to
basal value. B: at the end of 20 wk, %fat mass was measured by quantitative
magnetic resonance. C and D: IPGTT was performed on 16-h-fasted mice at
the end of the 20-wk treatment. C: plasma glucose concentrations 0, 15, 30, 45,
60, and 120 min after ip glucose injection. D: AUC of glucose excursion after
ip glucose injection. Results are means 
 SE. Ctrl-2, control 2; HFD-2,
high-fat diet 2. *P  0.05, **P  0.01, ***P  0.001 vs. Ctrl-2.
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feeding on the UPR was measured separately in slow soleus
and fast tibialis anterior muscles, with the greatest effects
observed in the soleus. Whereas the tibialis anterior muscle is
a voluntary muscle that is used sporadically, the soleus is a
postural muscle in mice and is continuously active during
standing and locomotion. In the soleus muscle, BiP, IRE1,
MBTPS2, and PERK protein levels were increased more than
fivefold, whereas in the more phasically active tibialis anterior
muscle these changes were less pronounced. The difference
could be due to greater susceptibility of oxidative fibers to an
HFD, an additive effect of contractile activity and HFD on ER
stress or increased uptake of fatty acids in the soleus due to its
higher blood flow and metabolic requirements.
Based on previous in vitro experiments, the UPR has been
divided into three canonical pathways (21, 23, 35, 38, 48).
They can be summarized as follows, emphasizing the markers
measured in the present study: 1) IRE1 and its downstream
targets BiP and PDI; 2) active ATF6 and the protease that
cleaves it (i.e., MBTPS2) and its downstream targets BiP,
CHOP, and XBP1; 3) PERK and its downstream target ATF4.
We cannot relate the changes in ER stress markers that we
observed in vivo to the activation of any single pathway. For
example, the increase in IRE1 expression was accompanied
by an increase in BiP, whereas high-fat feeding in either the
soleus or the tibialis anterior muscle did not affect PDI expres-
sion. In the same way, ATF4 mRNA was increased without
any increase in PERK phosphorylation in the tibialis anterior
muscle. This may mean that by sampling only at 6 wk we
missed the transient changes, such as phosphorylation of
PERK, and measured only the more stable changes such as
ATF4 expression. Alternatively, 70% HFD for 6 wk leads to a
general induction of the UPR rather than the activation of a
specific sensor (ATF6, PERK, or IRE1) and its downstream
signaling, as would have been hypothesized from previous
in vitro experiments.
When the UPR is not sufficient to cope with ER stress,
inflammation and insulin resistance may develop. The 70%
HFD increased plasma levels of cytokines such as IL-6 and
IL-10, and this was associated with whole body glucose intol-
erance as demonstrated by the OGTT. In the same way,
glucose intolerance was also induced after 20 wk of a 45%
HFD. Taken together, these data confirm that a mild chronic
inflammatory state and glucose intolerance were induced by
high-fat feeding. However, the role of ER stress in the devel-
opment of these physiological conditions has yet to be deter-
mined.
A more serious consequence of failure of the UPR is
apoptosis. Caspase-12 has been proposed as a potential marker/
mediator of ER stress-induced apoptosis (42). Increased
caspase-12 activity has been identified in many neurodegen-
erative diseases, such as Parkinson’s, Alzheimer’s, or Hunting-
ton’s diseases (8, 14, 20), which are believed to be the result of
the fatal breakdown of the UPR. Caspase-12 is located at the
ER membrane, and two different mechanisms have been pro-
posed for its activation. The first involves an IRE1-TRAF2
complex and is called “ER stress dependent” (50), while the
Fig. 4. 45% HFD-induced UPR in mouse skeletal muscle. A: protein expressions of BiP, IRE1, MBTPS2, PDI, and phosphorylation of PERK. B: caspase-12
expression and cleavage in plantar flexor muscles after 20-wk HFD-2. C: mRNA level of ATF4, CHOP, XBP1s, and XBP1u in plantar flexor muscles after 20-wk
HFD-2. Results are means 
 SE. A value of 1 was arbitrarily assigned to control conditions to which HFD-2 were reported and expressed as fold basal. *P 
0.05, **P  0.01, ***P  0.001 vs. Ctrl-2.
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second, “ER stress independent”, is associated with increase in
calcium and caspase-7 activation (27). Despite an induction of
the UPR, the 70% HFD did not change the expression of
caspase-12 or its cleavage, suggesting that the degree of ER
stress induced by 6-wk 70% HFD did not exceed the muscular
capacity to refold/remove damaged proteins. Although no
effect of HFD was observed on caspase-12, the basal cleavage
pattern of this caspase seems to be different between soleus and
tibialis anterior muscles. In the soleus muscle, a high percent-
age of the protein was in the cleaved form, whereas in the
tibialis anterior, caspase-12 was found in its inactive total form.
Since the soleus is a postural muscle, it experiences more
frequent increases in intracellular calcium. The difference in
caspase-12 cleavage may indicate that, in muscle, caspase-12
activation is mediated by calcium-dependent mechanisms
rather than ER stress and may have other, apoptosis-indepen-
dent, roles.
In the present study, C2C12 cells were used to determine the
functional effects of ER stress. Tunicamycin and thapsigargin
were used as positive controls to which the effect of palmitic
acid could be compared. All three compounds dramatically
increased the expressions of BiP, IRE1, and phospho-PERK
at the protein level and CHOP, ATF4, and XBP1 spliced and
unspliced at the mRNA level. Since the UPR is known to
decrease protein synthesis and increase insulin resistance
and apoptosis, we directly or indirectly measured each of
Fig. 5. Chemically induced UPR in C2C12 myogenic cells. A: protein expression of BiP, IRE1, ATF6, and phosphorylation of PERK. B: caspase-12 expression
and cleavage. C: mRNA level of ATF4, CHOP, XBP1s, and XBP1u. D: %cleaved caspase-3 and cleaved poly ADP-ribose polymerase (PARP) after 17-h
treatment with tunicamycin (TN, 1 g/ml), thapsigargin (TG, 200 nM), or palmitic acid (PA, 1 mM) in C2C12 cells. E: dose-response curves of BiP and IRE1
protein expression and of PERK phosphorylation to increasing concentrations of PA (0–1,500 M). Results are means 
 SE. A value of 1 was arbitrarily
assigned to control conditions to which TN, TG, and PA values were reported and expressed as fold basal. *P  0.05, **P  0.01, ***P  0.001 vs. Ctrl.
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these events after palmitic acid treatment. Although palmitic
acid clearly increased the UPR in myogenic cells, protein
synthesis was the only physiological process that was af-
fected over the 17 h of our study. This suggests that protein
synthesis is the first process to be repressed in an effort to
slow down the accumulation of newly synthesized proteins
awaiting proper folding in the ER. A decrease in protein
synthesis in skeletal muscle would, over time, be expected
to lead to a decrease in lean body mass and, as a result, basal
metabolic rate and glucose uptake in response to insulin.
Whether the decrease in skeletal muscle protein synthesis in
response to fat-induced ER stress plays a role in insulin
resistance remains to be determined.
Recently, Sitnick et al. (39) have demonstrated that load-
induced skeletal muscle hypertrophy is impaired in high-fat-
fed mice. This decrease in hypertrophy was attributed to a
decrease in ribosomal biogenesis and mTORC1 activation.
mTORC1 is known to be physiologically inactivated only by
the 5=-AMP-activated protein kinase (AMPK) (43), and during
skeletal muscle overload AMPK1 is activated and slows
muscle hypertrophy (24, 25). However, high-fat feeding de-
creases AMPK activity (2, 22), so a different mechanism must
underlie the effect of HFD on skeletal muscle hypertrophy. To
determine whether ER stress could contribute to this decrease
in hypertrophy, we determined the rate of protein synthesis and
the activation of mTORC1 following treatment with palmitic
acid. Consistent with a role for ER stress in decreased load-
induced hypertrophy, palmitic acid decreased both basal pro-
tein synthesis and mTORC1 activation. It should be mentioned
that protein synthesis was not measured in vivo, and it thus
remains to be determined whether high-fat feeding under the
conditions used in the present study decreases basal, postpran-
dial, and/or load-induced protein synthesis.
We sought to confirm that mTORC1 activity was also
decreased after high-fat feeding in vivo. Contrary to our
in vitro observations, S6K1 phosphorylation tended to be
upregulated, in accord with previously published reports show-
ing that HFD increases S6K1 phosphorylation in the basal state
(1, 17). This finding is not incompatible with our in vitro data,
since the extended HFDs used in the in vivo models will result
in large-scale changes in the hormonal environment that may
contribute to the regulation of mTORC1 activity. It is also
possible that mTORC1 goes through cycles of activation-
inactivation during periods of high circulating fatty acids and
that the increase or decrease observed in S6K1 phosphorylation
is dependent on the time of death. These cycles might be the
result of decreases in mTORC1 activity due to ER stress
followed by compensatory/feedback upregulation due to a
resultant increase in IRS-1 signaling (45). The cycling of
mTORC1 activity is illustrated by two studies from the same
group using a genetic model of obesity and diabetes. At
baseline, obese Zucker rats display either decreased (16) or
increased (31) S6K1 phosphorylation compared with lean con-
trols. The only difference between the two studies is the age of the
rats at the time of the experiment, 12 (16) vs. 6 wk (31).
Therefore, it seems that the time course of study is an important
consideration when conducting studies on high-fat feeding and
protein synthesis.
It should also be mentioned that the relationship between ER
stress and mTORC1 is probably not unidirectional. A previous
report has shown that hyperactivation of mTOR such as seen in
tuberous sclerosis complex-deficient cells causes ER stress and
activates the UPR (30). We directly tested whether 6 or 24 h of
hyperactivation of mTORC1 by insulin was able to trigger the
UPR in C2C12 cells. In our conditions, insulin did not induce
the UPR at any time point studied. Interestingly, tunicamycin
activated the UPR before S6K1 phosphorylation decreased,
suggesting that in C2C12 cells the induction of ER stress
precedes the impairment in mTORC1 activity.
In conclusion, we show that a high-fat diet activates the
unfolded protein response in mouse skeletal muscle in vivo. In
addition, in vitro palmitic acid, like other well-known ER stress
inducers, triggered the unfolded protein response and also led
to a decrease in protein synthesis and the activity of mTORC1.
These findings suggest that components of the ER stress
pathway might contribute to a decrease in muscle mass and the
response to growth stimuli, as a result of metabolic syndrome.
Fig. 6. ER stress reduces mTORC1 activity.
A: palmitic acid (PA, 1 mM) reduces 35S incor-
poration. B: PA (1 mM), tunicamycin (TN, 1
g/l), and thapsigargin (TG, 200 nM) decrease
phosphorylation of S6K1 on Thr389. C: phosphor-
ylation of S6K1 on Thr389 and on Thr421/Ser424
after 6-wk HFD-1 and after 20-wk HFD-2.
D: phosphorylation of S6K1 (Thr389) and PERK
and expression of BiP after 6 and 24 h in C2C12
cells treated with TN alone (1 g/l), insulin
alone (Ins, 10 and 50 nM), or TN and insulin.
S6K1, 70-kDa ribosomal protein S6 kinase; TA,
tibialis anterior. Results are means 
 SE. **P 
0.01, ***P  0.001 vs. Ctrl.
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